Sonoma Pharmaceuticals
SNOA
#10409
Rank
โ‚ฌ5.38 M
Marketcap
3,16ย โ‚ฌ
Share price
-1.20%
Change (1 day)
17.01%
Change (1 year)

Revenue for Sonoma Pharmaceuticals (SNOA)

Revenue in 2025 (TTM): โ‚ฌ15.07 Million

According to Sonoma Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โ‚ฌ14.43 Million. In 2024 the company made a revenue of โ‚ฌ13.42 Million an increase over the revenue in the year 2023 that were of โ‚ฌ11.13 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sonoma Pharmaceuticals from 2005 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ15.07 M12.28%
2024 โ‚ฌ13.42 M20.58%
2023 โ‚ฌ11.13 M-4.87%
2022 โ‚ฌ11.7 M6.16%
2021 โ‚ฌ11.02 M-35.58%
2020 โ‚ฌ17.11 M6.52%
2019 โ‚ฌ16.06 M0.76%
2018 โ‚ฌ15.94 M12.34%
2017 โ‚ฌ14.19 M21.13%
2016 โ‚ฌ11.71 M-9.74%
2015 โ‚ฌ12.98 M23.49%
2014 โ‚ฌ10.51 M3.07%
2013 โ‚ฌ10.2 M-12.76%
2012 โ‚ฌ11.69 M25.46%
2011 โ‚ฌ9.32 M33.66%
2010 โ‚ฌ6.97 M51.21%
2009 โ‚ฌ4.61 M33.23%
2008 โ‚ฌ3.46 M24.15%
2007 โ‚ฌ2.78 M-12.82%
2006 โ‚ฌ3.19 M74.43%
2005 โ‚ฌ1.83 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Onconova Therapeutics
ONTX
โ‚ฌ0.19 M-98.67%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
โ‚ฌ0.54 B 3,690.91%๐Ÿ‡บ๐Ÿ‡ธ USA